Please select the eligibility criteria that correspond to the clinical trial below.
Title: Impact of a Decision Aid on Patient Participation in Decision Making and Resource Use in Low Risk Chest Pain Patients: A Randomized Trial
Brief Summary: We are doing a study to assess the impact of including patients in making decision regarding their own medical care in the emergency department. We will randomly assign them to either receive a decision aid or usual care. In doing this, we aim to increase patient satisfaction and safely decrease medical cost.


Options:
A: Inclusion Criteria:

* Male and female inpatients with a diagnosis of schizophrenia/schizoaffective disorder according to ICD 10
* between 18 and 60 years of age are eligible for the study
* informed consent
* inpatients

Exclusion Criteria:

* poor German language skills
B: Inclusion Criteria:

* Ages 40-80 years
* Their physician agreed to participate in the study
* Seen in practice for at least one year

Exclusion Criteria:

* Prior history of prostate cancer
* Presenting for acute medical visit
* Non-skin cancer
* Lung disease requiring oxygen
* Renal failure requiring dialysis
* Intensive care visit in last 6 months
* Need assistance with activities of daily living
C: Inclusion Criteria:

* Adults with a primary complaint of chest pain.
* Treating clinician's next consideration is observation unit admission for cardiac stress testing.

Exclusion Criteria:

* Initial cardiac troponin T value \>99th percentile (\>0.01ng/mL)
* History of coronary artery disease
* coronary revascularization procedure within the previous 30 days
* cocaine use within 72 hours by the clinician's initial history
* pregnancy
* patient cannot read English or have, in their clinician's judgment, major learning barriers, such as visual or hearing impairment or dementia that would compromise their ability to give written informed consent (or use the decision aid)
D: Inclusion criteria:

* Diagnosis of Type 2 DM according to criteria of the World Health Organisation of one or more years of disease duration.
* Age from 30 to 80 years.
* HbA1C ≥ 9% (DCCT) according to the last blood test carried out during the 12 months prior to inclusion in the study
* No changes in the treatment that can influence the main variable during the 3 months prior inclusion in the study.
* Accepting to participate in the study and signing of the informed consent form.

Exclusion criteria:

* Patient refuses to participate and any other condition that prevents signing the informed consent form.
* Other types of diabetes: Type 1 DM, gestational diabetes and diabetes secondary to other diseases.
* Pharmacological treatments that interfere with carbohydrate metabolism, such as steroids.
* Life expectancy under 2 years.
* Current treatment for cancer other than basocellular or epidermoid skin cancer.
* Severe mental disease and dementia.
* Heart failure Class III or IV (NYHA).
* Renal transplant or current treatment with dialysis.
* Alcohol and drug abuse.
* Pregnancy or intention to get pregnant.
* Breastfeeding.
* Chronic treatment with steroids; treatment with steroids during the 2 months prior inclusion in the study.
* Pharmacological treatment for weight loss during the 2 months prior to inclusion in the - study.
* Treatment with immunosuppressants.
* Haemoglobinopathies and chronic anaemia.
* Body Mass Index \> 45 mg/kg2 (1)
* Participation in clinical trials for medicines.
* Patients with conditions that prevent follow up and completion of protocol.

Answer: C